# Section 206: Lorazepam

---

Lorazepam
217
Lorazepam
Mechanism of Action
Potentiates the actions of GABA, especially in the limbic system and the reticular formation
Uses
Anxiety, irritability with psychiatric or organic disorders, preoperatively; insomnia; adjunct for endoscopic procedures, status epilepticus
Unlabeled uses: Antiemetic prior to chemotherapy, rectal use, alcohol withdrawal, seizure prophylaxis, agitation, insomnia, sedation
maintenance
Contraindications
Pregnancy (D), breastfeeding, hypersensitivity to benzodiazepines, benzyl alcohol; closed-angle glaucoma, psychosis, history of drug abuse,
COPD, sleep apnea
Precautions: Children <12 yr, geriatric patients, debilitated, renal/hepatic disease, addiction, suicidal ideation, abrupt discontinuation
Protocol Uses
Tachycardia With a Pulse – Adult (p43), Bradycardia With a Pulse – Adult (p44), Behavioral Emergencies – Adult (p47), OB General – Adult (p50),
Antipsychotic Overdose / Acute Dystonic Reaction – Adult (p55), Cocaine and Sympathomimetic Overdose – Adult (p55), Tricyclic Overdose –
Adult (p55), Seizure – Adult (p61), Bradycardia With a Pulse – Peds (p99), Seizure – Peds (p109)
Side Effects
CNS: Dizziness, drowsiness, confusion, headache, anxiety, tremors, stimulation, fatigue, depression, insomnia, hallucinations, weakness,
unsteadiness
CV: Orthostatic hypotension, ECG changes, tachycardia, hypotension; apnea, cardiac arrest (IV, rapid)
EENT: Blurred vision, tinnitus, mydriasis
GI: Constipation, dry mouth, nausea, vomiting, anorexia, diarrhea
Skin: Rash, dermatitis, itching
Misc: Acidosis
Pharmacokinetics
Metabolized by liver; excreted by kidneys; crosses placenta, excreted in breast milk; half-life 14 hr
IM: Onset 15-30 min, peak 1-1.5 hours; duration 6-8 hours
IV: Onset 5-15 min, peak unknown, duration 6-8 hours
Pregnancy Category – D
Interactions
Increase: Lorazepam effects—CNS depressants, alcohol, disulfiram, oral contraceptives
Decrease: Lorazepam effects—valproic acid
EMT Considerations
Assess: Anxiety (decrease in anxiety; mental status); Physical dependency (withdrawal symptoms: headache, nausea, vomiting, muscle pain,
weakness, tremors, seizures)
Perform/provide: Assistance with ambulation during beginning therapy, since drowsiness, dizziness occurs; Refrigerate parenteral form
Evaluate: Therapeutic response: decreased anxiety, restlessness
Treatment of Overdose
GI lavage, VS, supportive care, flumazenil
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic
M Medical Control
EMR
